Article
TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis.
Scientific reports - 3 Nov 2022
Duarte Victor Hugo Rezende, Cruz Marina Sampaio, Bertolami Adriana, Hirata Mario Hiroyuki, Hirata Rosario Dominguez Crespo, Luchessi André Ducati, Silbiger Vivian Nogueira
Abstract excerpt
TREML4 and other members of the triggering receptor expressed in the myeloid cell family are associated with a risk of atherosclerosis and progression in coronary artery disease, acute coronary syndrome, and coronary artery calcification. Herein, the relationship between TREML4 expression and its polymorphisms (rs2803495 and rs280396) was evaluated in patients with subclinical atherosclerosis (n = 340) and heart...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
